Plant-based products are a one-of-a-kind source of favoured molecules with a wide scaffold variety and broad multi-target potential for the treatment of complicated disorders. Among multi-target NPs, alkaloids have showed anti-inflammatory, anticancer, cardioprotective, and neuroprotective effects, supporting their promise in the treatment of chronic multifactorial disorders. Several recent investigations have revealed that isoquinoline alkaloids (IAs) have multimodal potential, sparking growing interest in the polypharmacological research of these small molecules, particularly in the field of neurological illnesses and cancer. IAs are a broad and diversified category of nitrogenous compounds that are extensively dispersed in living organisms, mostly in plants family. Isoquinolines are known as highly conserved metabolites in early vascular plants at the chemotaxonomic level; moreover, biochemical and molecular phylogenetic investigations have revealed that these alkaloids play an evolutionarily monophyletic role in basal angiosperms.As a result, medicinal chemistry has been experimenting with various ways in order to overcome the constraints of existing paradigms and increase the effectiveness of novel therapeutic molecules. In this context, the search or design of multi-target medications has shown an accelerated breakthrough; in fact, this strategy has sparked the interest of both the scientific community and the pharmaceutical business, allowing several multimodal agents already on the market to be positioned.
Cite this article:
Arjun Singh. Plant-based Isoquinoline Alkaloids: A Chemical and Pharmacological Profile of Some Important Leads. Asian Journal of Research in Chemistry. 2023; 16(1):43-8. doi: 10.52711/0974-4150.2023.00008
Arjun Singh. Plant-based Isoquinoline Alkaloids: A Chemical and Pharmacological Profile of Some Important Leads. Asian Journal of Research in Chemistry. 2023; 16(1):43-8. doi: 10.52711/0974-4150.2023.00008 Available on: https://ajrconline.org/AbstractView.aspx?PID=2023-16-1-8
1. World Health Organization. WHO traditional medicine strategy: 2014-2023. World Health Organization, 2013.
2. World Health Organization. WHO global report on traditional and complementary medicine 2019. World Health Organization, 2019.
3. Qi, Zhang. "Who traditional medicine strategy. 2014-2023." Geneva: World Health Organization 188 (2013).
4. World Health Organization. "The regional strategy for traditional medicine in the Western Pacific (2011-2020)." (2012).
5. World Health Organization. Regional strategy for traditional medicine in the Western Pacific. Manila: WHO Regional Office for the Western Pacific, 2002.
6. Kasilo, Ossy MJ, and Jean‐Baptiste Nikiema. "World Health Organization perspective for traditional medicine." Novel Plant Bioresources: Applications in Food, Medicine and Cosmetics (2014): 23-42.
7. Zhang, Qi, Aditi Sharan, Stéphane Alexandre Espinosa, Daniel Gallego-Perez, and John Weeks. "The path toward integration of traditional and complementary medicine into health systems globally: The World Health Organization report on the implementation of the 2014–2023 strategy." The Journal of Alternative and Complementary Medicine 25, no. 9 (2019): 869-871.
8. Hajare, Ashok A, Sachin S Mali, Sonali S Gorde, Jyoti D Thorat, and Sachin S Salunkhe. “Narrative Review: A Rational Approach to Needle Free Insulin Technology,” 2014, 11.
9. Lakshmi, K. “Effectiveness of Nursing Care of Antenatal Mothers with Gestational Diabetes Mellitus.” Asian Journal of Nursing Education and Research 10, no. 3 (2020): 286.
10. Raju, Vidya, Jasmine Joy Bell, N. J. Merlin, and Shaiju S Dharan. “Ethno Pharmacological Uses of Artocarpus Altilis -A Review.” Asian Journal of Pharmaceutical Research 7, no. 4 (2017): 239.
11. Somwanshi, Sachin B., Punam D. Bairagi, and Kiran B. Kotade. “Study of Gestational Diabetes Mellitus: A Brief Review.” Asian Journal of Pharmaceutical Research 7, no. 2 (2017): 118.
12. Yousaf, Aqsa, and Sammia Shahid. “The Study of Anethum Graveolens L. (Dill) in the Case of Diabetes Mellitus (DM).” Asian Journal of Research in Pharmaceutical Science 10, no. 4 (2020): 248–56.
13. Chanda D, Prieto-Lloret J, Singh A, Iqbal H, Yadav P, Snetkov V, et al. Glabridin-induced vasorelaxation: Evidence for a role of BKCa channels and cyclic GMP. Life Sciences. 2016 Nov 15; 165:26–34. https://doi.org/10.1016/j.lfs.2016.09.018.
14. Gautam Y, Dwivedi S, Srivastava A, Hamidullah, Singh A, Chanda D, et al. 2-(3′,4′-Dimethoxybenzylidene)tetralone induces anti-breast cancer activity through microtubule stabilization and activation of reactive oxygen species. RSC Adv. 2016 Apr 5; 6(40):33369–79. https://doi.org/10.1039/C6RA02663J.
15. Hamid AA, Hasanain M, Singh A, Bhukya B, Omprakash, Vasudev PG, et al. Synthesis of novel anticancer agents through opening of spiroacetal ring of diosgenin. Steroids. 2014 Sep; 87:108–18. https://doi.org/10.1016/j.steroids.2014.05.025.
16. Hamid AA, Kaushal T, Ashraf R, Singh A, Chand Gupta A, Prakash O, et al. (22β,25R)-3β-Hydroxy-spirost-5-en-7-iminoxy-heptanoic acid exhibits anti-prostate cancer activity through caspase pathway. Steroids. 2017 Mar; 119:43–52. https://doi.org/10.1016/j.steroids.2017.01.001.
17. Jain S, Singh A, Khare P, Chanda D, Mishra D, Shanker K, et al. Toxicity assessment of Bacopa monnieri L. grown in biochar amended extremely acidic coal mine spoils. Ecological Engineering. 2017 Nov; 108:211–9. https://doi.org/10.1016/j.ecoleng.2017.08.039.
18. Khwaja S, Fatima K, Hasanain M, Behera C, Kour A, Singh A, et al. Antiproliferative efficacy of curcumin mimics through microtubule destabilization. European Journal of Medicinal Chemistry. 2018 May; 151:51–61. https://doi.org/10.1016/j.ejmech.2018.03.063.
19. Kumar BS, Ravi K, Verma AK, Fatima K, Hasanain M, Singh A, et al. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition. Bioorganic and Medicinal Chemistry. 2017 Feb; 25(4):1364–73. https://doi.org/10.1016/j.bmc.2016.12.043.
20. Mishra D, Jyotshna, Singh A, Chanda D, Shanker K, Khare P. Potential of di-aldehyde cellulose for sustained release of oxytetracycline: A pharmacokinetic study. International Journal of Biological Macromolecules. 2019 Sep; 136:97–105. https://doi.org/10.1016/j.ijbiomac.2019.06.043.
21. Sathish Kumar B, Kumar A, Singh J, Hasanain M, Singh A, Fatima K, et al. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization. European Journal of Medicinal Chemistry. 2014 Oct; 86:740–51. https://doi.org/10.1016/j.ejmech.2014.09.033.
22. Sathish Kumar B, Singh A, Kumar A, Singh J, Hasanain M, Singh A, et al. Synthesis of neolignans as microtubule stabilisers. Bioorganic & Medicinal Chemistry. 2014 Feb; 22(4):1342–54. https://doi.org/10.1016/j.bmc.2013.12.067.
23. Singh A, Kumar BS, Alam S, Iqbal H, Shafiq M, Khan F, et al. Diethyl-4,4ʹ-dihydroxy-8,3ʹ-neolign-7,7ʹ-dien-9,9ʹ-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels. European Journal of Pharmacology. 2017 Mar; 799:84–93. https://doi.org/10.1016/j.ejphar.2017.01.044.
24. Singh A, Kumar BS, Iqbal H, Alam S, Yadav P, Verma AK, et al. Antihypertensive activity of diethyl-4,4’-dihydroxy-8,3’-neolign-7,7’-dien-9,9’-dionate: A continuation study in L-NAME treated wistar rats. Eur J Pharmacol. 2019 Sep 5; 858:172482. https://doi.org/10.1016/j.ejphar.2019.172482.
25. Singh A, Mohanty I, Singh J, Rattan S. BDNF augments rat internal anal sphincter smooth muscle tone via RhoA/ROCK signaling and nonadrenergic noncholinergic relaxation via increased NO release. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2020 Jan 1; 318(1):G23–33. https://doi.org/10.1152/ajpgi.00247.2019.
26. Singh A, Rattan S. BDNF rescues aging-associated internal anal sphincter dysfunction. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2021 Jul 1; 321(1):G87–97. https://doi.org/10.1152/ajpgi.00090.2021
27. Singh, A., Singh, J., Rattan, S., 2021. Evidence for the presence and release of BDNF in the neuronal and non‐neuronal structures of the internal anal sphincter. Neurogastroenterology& Motility. 2021 Feb 7; 00; e14099. https://doi.org/10.1111/nmo.14099
28. Singh A, Fatima K, Singh A, Behl A, Mintoo MJ, Hasanain M, et al. Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule. European Journal of Pharmaceutical Sciences. 2015 Aug 30; 76:57–67. https://doi.org/10.1016/j.ejps.2015.04.020.
29. Singh A, Fatima K, Srivastava A, Khwaja S, Priya D, Singh A, et al. Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer. Chem Biol Drug Des. 2016 Nov; 88(5):625–34. https://doi.org/10.1111/cbdd.12805.
30. Yadav P, Iqbal H, Kumar K, Kumar P, Mishra D, Singh A, et al. 2-Benzyllawsone protects against polymicrobial sepsis and vascular hyporeactivity in swiss albino mice. European Journal of Pharmacology. 2022 Feb; 917:174757. https://doi.org/10.1016/j.ejphar.2022.174757.
31. Manmohan, S., Arjun, S., Khan, S. P., Eram, S., &Sachan, N. K., 2012. Green chemistry potential for past, present and future perspectives. International Research Journal of Pharmacy, 2012 Feb; 3, 31-36. https://doi.org/10.1016/j.ejphar.2022.174757.
32. Singh A, Kumar BS, Alam S, Iqbal H, Shafiq M, Khan F, Negi AS, Hanif K, Chanda D. Corrigendum to "Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits AH activity in rats through increase in intracellular cGMP level and blockade of calcium channels" Eur J Pharmacol. 2017 Jul 5; 806:111. doi: 10.1016/j.ejphar.2017.04.033.
33. Singh, A., R. Sharma, K. M. Anand, S. P. Khan, and N. K. Sachan. "Food-drug interaction." International Journal of Pharmaceutical & Chemical Science 2012 Feb; 1(1) 264-279. doi: 10.1016/j.ejphar.2017.04.033.
34. Thanh-Hoang, N.-V.; Loc, N.; Nguyet, D.; Thien-Ngan, N.; Khang, T.; Cao, H.; Le, L. Plant Metabolite Databases: From Herbal Medicines to Modern Drug Discovery. J. Chem. Inf. Model. 2020, 60, 1101–1110.
35. Kumar, S.; Malhotra, R.; Kumar, D. Euphorbia hirta: Its chemistry, traditional and medicinal uses, and pharmacological activities. Pharmacogn. Rev. 2010, 4, 58–61.
36. Ramu,F.A.; Kumar,S.R.ScientificevaluationoftraditionallyknowninsulinplantCostusspeciesforthe treatment of diabetes in human. Int. J. Curr. Res. Biosci. Plant Biol. 2016, 3, 87–91.
37. Jayasri,M.A.; Gunasekaran,S.; Radha,A.; Mathew,T.L. Antidiabetic effect of Costuspictus leaves in normal and streptozotocin-induced diabetes rats. Int. J. Diabetes Metab. 2008, 16, 117–122.
38. Sidhu, A.K.; Wani, S.; Tamboli, P.S.; Patil, S.N. In Vitro Evaluation of Anti-Diabetic Activity of Leaf and Callus Extracts of Costus pictus. Int. J. Recent Sci. Res. 2014, 3, 1622–1625.
39. Prakash,K.; Harini,H.; Rao,A.; Rao,P.N. A review on Isulin plant(CostusigneusNak). Pharmacogn.Rev. 2014, 8, 67–72.
40. Radha Devi, G.M. A Comprehensive Review On CostusPictusD. Don. Int.J.Pharm.Sci.Res.2019, 10, 3187–3195.
41. Dhar, M.L., Dhar, M.M., Dhawan, B.N., Mehrotra, B.N., Ray, C. 1968. Screening of Indian plants for biological activity. Indian Journal of Experimental Biology 6 (4), 232-247.
42. Dhawan, B.N., Dubey, M.P., Mehrotra, B.N., Rastogi, R.P., Tandon, J.S. 1980. Screening of Indian plants for biological activity. Part 9. Indian Journal of Experimental Biology 18, 594-606.
43. Chattopadhyay RR. A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethnopharmacol. 1999; 67(3):367-372. doi:10.1016/s0378-8741(99)00095-1
44. Joglekar, G.V., Chaudhary, N.Y., Aiaman, R. 1959. Effect of Indian medicinal plants on glucose absorption in mice. J Clin BiochemNutr. 2007 May; 40(3):163-73. doi: 10.3164/jcbn.40.163.
45. Panlasigui LN, Panlilio LM, Madrid JC. Glycaemic response in normal subjects to five different legumes commonly used in the Philippines. Int J Food Sci Nutr. 1995; 46(2):155-160. doi:10.3109/09637489509012544
46. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995; 2(2):137-189. doi:10.1016/S0944-7113(11)80059-0
47. Rao, P.V., Ushabala, P., Seshiah, V., Ahuja, M.M., Mather, H.M. 1989. The Eluru survey: prevalence of known diabetes in a rural Indian population. Diabetes Res Clin Pract. 1989; 7(1):29-31. doi:10.1016/0168-8227(89)90041-7
48. Bading TB., Bouckandou, M., Souza, A., BourobouBourobou, H.P., MacKenzie, L.S., Lione, L., An overview of anti-diabetic plants used in Gabon: Pharmacology and toxicology. Journal of Ethnopharmacology 2018 Apr 24; 216:203-228. doi: 10.1016/j.jep.2017.12.036.
49. Chin, Y., Balunas, M., Chai, H., Kinghorn, A., 2006. Drug Discovery From Natural Sources. AAPS J. 2006; 8(2):E239-E253. Published 2006 Apr 14. doi:10.1007/BF02854894.
50. Choudhury H, Pandey M, Hua CK, et al. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. J Tradit Complement Med. 2017; 8(3):361-376. Published 2017 Nov 29. doi:10.1016/j.jtcme.2017.08.012
51. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry. 2004; 65(8):995-1016. doi:10.1016/j.phytochem.2004.03.005
52. Newman, D.J., Cragg, G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016. 79, 629–661.
53. Newman, D.J., Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012. 75, 311–335. doi:10.1016/j.phytochem.2010.03.009
54. Rao, M.U., Sreenivasulu, M., Chengaiah, B., Reddy, K.J., Chetty, C.M., n.d. Herbal Medicines for Diabetes Mellitus: A Review 11.doi:10.1016/j.phytochem.2004.03.005
55. Ward, R.S. Lignans, neolignans and related compounds. Nat. Prod. Rep. 1999.16, 75–96.doi:10.1016/j.phytochem.1999.03.005